Authors:
SYRJANEN K
NURMI T
MANTYJARVI R
ILONEN J
SYRJANEN S
SURCEL HM
YLISKOSKI M
VAYRYNEN M
CHANG F
SAARIKOSKI S
Citation: K. Syrjanen et al., HLA TYPES IN WOMEN WITH CERVICAL HUMAN PAPILLOMAVIRUS (HPV) LESIONS PROSPECTIVELY FOLLOWED UP FOR 10 YEARS, Cytopathology, 7(2), 1996, pp. 99-107
Authors:
MAENPAA J
KIVINEN S
RAISANEN I
SIPILA P
VAYRYNEN M
GROHN P
Citation: J. Maenpaa et al., COMBINED INTRAPERITONEAL INTERFERON-ALPHA-2B AND MITOXANTRONE IN REFRACTORY OVARIAN-CANCER, Annales chirurgiae et gynaecologiae, 83, 1994, pp. 25-27
Authors:
TERVAHAUTA AI
SYRJANEN SM
VAYRYNEN M
SAASTAMOINEN J
SYRJANEN KJ
Citation: Ai. Tervahauta et al., EXPRESSION OF P53 PROTEIN RELATED TO THE PRESENCE OF HUMAN PAPILLOMAVIRUS (HPV) DNA IN GENITAL CARCINOMAS AND PRECANCER LESIONS, Anticancer research, 13(4), 1993, pp. 1107-1112
Citation: T. Lahtinen et al., ICRU REFERENCE POINTS AND MAXIMUM DOSES OF RECTUM AND BLADDER IN INTRACAVITARY RADIOTHERAPY, Radiotherapy and oncology, 28(2), 1993, pp. 174-176
Authors:
MERVAALA E
ALHAINEN K
HELKALA EL
PARTANEN J
JOUSMAKI V
VAYRYNEN M
HEINONEN E
RIEKKINEN P
Citation: E. Mervaala et al., ELECTROPHYSIOLOGICAL AND NEUROPSYCHOLOGICAL EFFECTS OF A CENTRAL ALPHA(2)-ANTAGONIST ATIPAMEZOLE IN HEALTHY-VOLUNTEERS, Behavioural brain research, 55(1), 1993, pp. 85-91
Authors:
KATAJA V
SYRJANEN S
YLISKOSKI M
HIPPELAINEN M
VAYRYNEN M
SAARIKOSKI S
MANTYJARVI R
JOKELA V
SALONEN JT
SYRJANEN K
Citation: V. Kataja et al., RISK-FACTORS ASSOCIATED WITH CERVICAL HUMAN PAPILLOMAVIRUS INFECTIONS- A CASE-CONTROL STUDY, American journal of epidemiology, 138(9), 1993, pp. 735-745